These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 7867012

  • 1. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW.
    Cancer Res; 1995 Mar 01; 55(5):999-1001. PubMed ID: 7867012
    [Abstract] [Full Text] [Related]

  • 2. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 01; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 3. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul 01; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 4. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 5. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K, Gries H, Bolik E, Cervós-Navarro J, Tschairkin IN, Patt S.
    Histol Histopathol; 1997 Jul 15; 12(3):611-6. PubMed ID: 9225141
    [Abstract] [Full Text] [Related]

  • 6. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 15; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 7. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical and molecular analysis of bax, bcl-2 and p53 genes in laryngeal squamous cell carcinomas.
    Fracchiolla NS, Capaccio P, Carboni N, Pagliari AV, Neri A, Ronchett D, Pruner G, Silvotti MG, Pignataro L, Buffa R, Broich G.
    Anticancer Res; 1999 Mar 15; 19(2A):1043-51. PubMed ID: 10368653
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 10. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM, Saya H, Moser RP.
    Mod Pathol; 1991 Sep 15; 4(5):671-4. PubMed ID: 1758878
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer.
    Sierra A, Castellsagué X, Tórtola S, Escobedo A, Lloveras B, Peinado MA, Moreno A, Fabra A.
    Clin Cancer Res; 1996 Nov 15; 2(11):1887-94. PubMed ID: 9816145
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 15; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
    Shinoura N, Muramatsu Y, Nishimura M, Yoshida Y, Saito A, Yokoyama T, Furukawa T, Horii A, Hashimoto M, Asai A, Kirino T, Hamada H.
    Cancer Res; 1999 Nov 01; 59(21):5521-8. PubMed ID: 10554029
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 17. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T, Omura-Minamisawa M, Kang Y, Cheng C, Inoue T.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1485-95. PubMed ID: 18640498
    [Abstract] [Full Text] [Related]

  • 18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O.
    Cancer; 1997 Sep 15; 80(6):1034-45. PubMed ID: 9305703
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 15; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.